Enanta Pharmaceuticals (ENTA) 2025 Conference Transcript

Enanta Pharmaceuticals (ENTA) 2025 Conference September 03, 2025 08:35 AM ET Speaker2Welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Enanta Pharmaceuticals, Inc., a company that's developing drugs in viral antivirals and immunology indications. I'm pleased to introduce Jay R. Luly, President and Chief Executive Officer, and Tara L. Kieffer, Chief Product Strategy Officer. We'd like to welcome you, but also my condolences for Paul.Spe ...